BASEL, Switzerland,
Sept. 20 /PRNewswire-FirstCall/ -
Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) is a
worldwide based biotechnological enterprise involved in the unique
international niche of clinical neuroscience diagnostic testing.
Neuro-Biotech's presently has the opportunity to market 12 clinical
"Neuro Blood Tests" through partnerships. Neuro-Biotech's
proprietary diagnostic tests are without equal in being rapidly
done as an essential complement to current clinical laboratory
testing procedures, by being non-invasive, sensitive, and reliable.
This will provide general practitioners and specialists alike,
useful medical parameters in the analysis and treatment of
workplace stress-related diseases and mental-health disorders, such
as Alzheimer's.
As a result of more than 20 years of research and development
(R&D), Neuro-Biotech Corp.'s specific expertise is the
understanding of the communication between the brain and the human
body and their various influences on the peripheral systems, in
order to maintain the internal equilibrium of a person's state of
mind.
This exclusive understanding of the relationships between the
neurotransmitter families within the brain led to the development
of a portfolio of in vitro diagnostic blood tests. They will be
used for the detection, prevention, monitoring and follow-up of the
major psycho-social environmental diseases. They can be
stress-related, socio-professional and occupational diseases, such
as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic
Syndrome (PS); Cardiovascular diseases like Essential Hypertension
or Arrhythmia; Neurodegenerative diseases such as Alzheimer or
Parkinson's Disease as well as Mental-Health Disorders in the vein
of Depression and Schizophrenia
Caregivers can now evaluate and establish an individual's
ability to react to stress by monitoring bio-indicators within the
blood or other biological fluids. Efficient and improved patient
supervision, treatment and follow-up care can be instituted.
Clinical Neuroscience-related diseases can be difficult
to diagnose and complex to treat.
If we don't know the full state of health of an individual
and the progression of the therapy...
How can we truly manage the care and rehabilitation?
Neuro-Biotech Corp. has the solution!
SOURCE Neuro-Biotech Corp.
Copyright . 20 PR Newswire